Dendritic-cell-based therapeutic vaccination against cancer

被引：163

作者：

Nestle, FO ^{[1
]}

Farkas, A ^{[1
]}

Conrad, C ^{[1
]}

机构：

[1] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland

来源：

CURRENT OPINION IN IMMUNOLOGY | 2005年 / 17卷 / 02期

关键词：

D O I：

10.1016/j.coi.2005.02.003

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Early clinical trials, in which over 1000 cancer patients received dendritic cell (DC) vaccines, tested different vaccine preparations, but they did not always induce sufficient acquired immunity or meet the expected level of tumor regressions. Current studies aim to improve the DC vaccine approach and capture the potential of these cells in order to gain access to lymphoid tissues and induce strong cell-mediated immunity. DC clinical trials are moving towards a more professional environment, in accordance with the latest quality standards. This explains the current need for innovative well designed trials with defined endpoints that induce robust anti-tumor immunity.

引用

页码：163 / 169

页数：7

共 67 条

[11] Conrad C, 2003, CURR OPIN MOL THER, V5, P405
[12] Phenotypical and functional characterization of clinical grade dendritic cells
de Vries, IJM
Eggert, AAO
Scharenborg, NM
Vissers, JLM
Lesterhuis, WJ
Boerman, OC
Punt, CJA
Adema, BJ
Figdor, CG
[J]. JOURNAL OF IMMUNOTHERAPY, 2002, 25 (05) : 429 - 438
[13] de Vries IJM, 2003, CLIN CANCER RES, V9, P5091
[14] Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34+-derived dendritic cell vaccination:: A phase I trial in metastatic melanoma
Di Nicola, M
Carlo-Stella, C
Mortarini, R
Baldassari, P
Guidetti, A
Gallino, GF
Del Vecchio, M
Ravagnani, F
Magni, M
Chaplin, P
Cascinelli, N
Parmiani, G
Gianni, AM
Anichini, A
[J]. CLINICAL CANCER RESEARCH, 2004, 10 (16) : 5381 - 5390
[15] DIETZ AB, IN PRESS CYTOTHERAPY
[16] Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: Implications for cancer immunotherapy protocols
Dullaers, M
Breckpot, K
Van Meirvenne, S
Bonehill, A
Tuyaerts, S
Michiels, A
Straetman, L
Heirman, C
De Greef, C
Van Der Bruggen, P
Thielemans, K
[J]. MOLECULAR THERAPY, 2004, 10 (04) : 768 - 779
[17] Intratumoral dendritic cell vaccination elicits potent tumoricidal immunity against malignant glioma in rats
Ehtesham, M
Kabos, P
Gutierrez, MAR
Samoto, K
Black, KL
Yu, JS
[J]. JOURNAL OF IMMUNOTHERAPY, 2003, 26 (02): : 107 - 116
[18] Dendritic cell-based cancer immunotherapy
Engleman, EG
[J]. SEMINARS IN ONCOLOGY, 2003, 30 (03) : 23 - 29
[19] Dendritic cell immunotherapy: mapping the way
Figdor, CG
de Vries, IJM
Lesterhuis, WJ
Melief, CJM
[J]. NATURE MEDICINE, 2004, 10 (05) : 475 - 480
[20] Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
Fong, L
Hou, YF
Rivas, A
Benike, C
Yuen, A
Fisher, GA
Davis, MM
Engleman, EG
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (15) : 8809 - 8814

← 1 2 3 4 5 6 7 →